Analysts Offer Predictions for Daré Bioscience Q1 Earnings
Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Equities research analysts at HC Wainwright upped their Q1 2025 earnings estimates for Daré Bioscience in a report released on Tuesday, April 1st. HC Wainwright analyst D. Tsao now expects that the biotechnology company will post earnings per share of ($0.57) for the quarter, up from their […]
